Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

U.S. Physical Therapy, Inc. Common Stock (NY:USPH)

85.16 +1.05 (+1.25%)
Streaming Delayed Price Updated: 11:47 AM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about U.S. Physical Therapy, Inc. Common Stock

< Previous 1 2 3 Next >
1 Volatile Stock Worth Your Attention and 2 We Avoid
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
Topics Supply Chain
USPH Q2 Deep Dive: Volume Growth and Cost Controls Support Upbeat Outlook
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) announced better-than-expected revenue in Q2 CY2025, with sales up 18% year on year to $197.3 million. Its non-GAAP profit of... 
Via StockStory
Topics Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
USPH EPS Drops 20 Percent on Miss
Via The Motley Fool
Earnings Scheduled For August 6, 2025
 
Via Benzinga
Earnings Scheduled For May 7, 2025
 
Via Benzinga
What Analysts Are Saying About US Physical Therapy Stock
 
Via Benzinga
Earnings Scheduled For February 26, 2025
 
Via Benzinga
Unveiling 6 Analyst Insights On US Physical Therapy
 
Via Benzinga
U.S. Physical Therapy’s (NYSE:USPH) Q2: Strong Sales
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 18% year on year to $197.3 million. Its non-GAAP profit of... 
Via StockStory
U.S. Physical Therapy Earnings: What To Look For From USPH
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be reporting results this Wednesday after market hours. Here’s what investors should know. 
Via StockStory
Topics World Trade
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Price Over Earnings Overview: US Physical Therapy
 
Via Benzinga
Outpatient & Specialty Care Stocks Q1 Earnings Review: U.S. Physical Therapy (NYSE:USPH) Shines
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how U.S. Physical Therapy... 
Via StockStory
Topics Artificial Intelligence
1 Profitable Stock on Our Buy List and 2 to Be Wary Of
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
2 Healthcare Stocks with Competitive Advantages and 1 to Keep Off Your Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
1 Small-Cap Stock to Research Further and 2 to Keep Off Your Radar
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
USPH Q1 Earnings Call: Management Highlights Volume Growth and Contracting Initiatives Amid Medicare Headwinds
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 18.1% year on year to $183.8 million. Its... 
Via StockStory
1 Cash-Producing Stock on Our Buy List and 2 to Be Wary Of
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
U.S. Physical Therapy (NYSE:USPH) Reports Strong Q1
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 18.1% year on year to $183.8 million. Its... 
Via StockStory
Earnings To Watch: U.S. Physical Therapy (USPH) Reports Q1 Results Tomorrow
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be announcing earnings results tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks in Hot Water
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Encompass Health (NYSE:EHC) and its peers. 
Via StockStory
Topics Artificial Intelligence
U.S. Physical Therapy (USPH): Buy, Sell, or Hold Post Q4 Earnings?
Although the S&P 500 is down 6.9% over the past six months, U.S. Physical Therapy’s stock price has fallen further to $70.65, losing shareholders 14.1% of their capital. This might have investors... 
Via StockStory
Topics Stocks Supply Chain
Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH)
Looking back on outpatient & specialty care stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including U.S. Physical Therapy (NYSE:USPH) and its peers. 
Via StockStory
Topics Artificial Intelligence
U.S. Physical Therapy (USPH) To Report Earnings Tomorrow: Here Is What To Expect
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be announcing earnings results tomorrow after market close. Here’s what investors should know. 
Via StockStory
US Physical Therapy Positioned For Success Despite Medicare Challenges, Analyst Optimistic On Unique Growth Strategy
JMP Securities initiates U.S. Physical Therapy (USPH) coverage with a $113 target, citing growth driven by acquisitions, partnerships, and strategic focus. 
Via Benzinga
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.